We are live on
!
Find out more
Milestone Pharmaceuticals
MIST
MIST
48 hedge funds and large institutions have $59M invested in Milestone Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
3.2% less ownership
Funds ownership: 65.22% → 62.01% (-3.2%)
4% less funds holding
Funds holding: 50 → 48 (-2)
31% less capital invested
Capital invested by funds: $85.5M → $59M (-$26.6M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $17K
Holders
48
Holders Change
-2
Holders Change %
-4%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
20
Reduced
12
Closed
6
Calls
–
Puts
$17K
Net Calls
-$17K
Net Calls Change
-$383K
Top Buyers
| 1 |
BlackRock
New York
|
+$2.18M |
| 2 |
AAA
Affinity Asset Advisors
New York
|
+$380K |
| 3 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$198K |
| 4 |
Squarepoint
New York
|
+$172K |
| 5 |
LPC
Lion Point Capital
New York
|
+$94.3K |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.93M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.28M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$578K |
| 4 |
JP Morgan Chase
New York
|
-$486K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$354K |
